← FDA DRUG APPROVALS

FDA NDA · NDA016419

PROPRANOLOL HYDROCHLORIDE

Sponsor: BAXTER HLTHCARE CORP

APPLICATION
NDA016419
TYPE
NDA
ORIGINAL APPROVAL
1967-11-13
LATEST ACTION
2008-04-01
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROPRANOLOL HYDROCHLORIDE · ReferenceDiscontinued
PROPRANOLOL HYDROCHLORIDE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

Approval history

2008-04-01Labeling · Supplement 29 · standardLabelAP
2006-07-24Labeling · Supplement 26 · standardLetterAP
2002-02-06Labeling · Supplement 24 · standardAP
2001-12-07Manufacturing (CMC) · Supplement 25 · priorityAP
2001-02-14Manufacturing (CMC) · Supplement 23 · priorityAP
1999-08-22Labeling · Supplement 22 · standardAP
1997-11-07Labeling · Supplement 21 · standardAP
1990-02-14Labeling · Supplement 20AP
1988-12-06Manufacturing (CMC) · Supplement 19 · priorityAP
1988-08-12Manufacturing (CMC) · Supplement 18 · priorityAP
1985-06-18Manufacturing (CMC) · Supplement 17 · priorityAP
1982-06-23Manufacturing (CMC) · Supplement 16 · priorityAP
1982-06-23Manufacturing (CMC) · Supplement 15 · priorityAP
1981-03-12Manufacturing (CMC) · Supplement 14 · priorityAP
1979-01-17Labeling · Supplement 12AP
1978-12-12Labeling · Supplement 13AP
1978-08-21Labeling · Supplement 9AP
1967-11-13Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →